Rotinen Díaz, Mirja SofiaEncío Martínez, Ignacio2021-01-112021-01-1120202305-584710.21037/atm.2020.04.51https://academica-e.unavarra.es/handle/2454/38975This article is a comment of 'Han J, Lv W, Sheng H, et al. Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells. Ann Transl Med 2019;7:539'.4 p.application/pdfengThis is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license).Lung cancerTreatmentEcliptasaponin ACutting down on lung cancer: Ecliptasaponin A is a novel therapeutic agentinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccess